| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Tegobuvir |
5-[[6-[2,4-双(三氟甲基)苯基]-3-哒嗪基]甲基]-2-(2-氟苯基)-5H-咪唑并[4,5-C]吡啶 |
1000787-75-6 |
详细
|
| JAK3-IN-6 |
|
1443235-95-7 |
详细
|
| MRT68921 HCI |
|
2070014-87-6 |
详细
|
| Aripiprazole Dimer Impurity |
阿立哌唑二聚物 |
1797986-18-5 |
详细
|
| ACY-775 |
|
1375466-18-4 |
详细
|
| yGsy2p-IN-1 |
|
2415003-97-1 |
详细
|
| Motolimod (VTX-2337) |
2-氨基-N,N-二丙基-8-(4-(吡咯烷-1-羰基)苯基)-3H-苯并[b]氮杂-4-甲酰胺 |
926927-61-9 |
详细
|
| SUN11602 |
|
704869-38-5 |
详细
|
| CHIR-090 |
|
728865-23-4 |
详细
|
| NVS-PAK1-1 |
|
1783816-74-9 |
详细
|
| PF03274167 |
|
900510-03-4 |
详细
|
| UNC1215 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1-基)哌啶-1-基)甲酮) |
1415800-43-9 |
详细
|
| SH-4-54 |
|
1456632-40-8 |
详细
|
| GDC-0084 |
|
1382979-44-3 |
详细
|
| ETP-46321 |
|
1252594-99-2 |
详细
|
| Grapiprant |
|
415903-37-6 |
详细
|
| MKC3946 |
|
1093119-54-0 |
详细
|
| Fatostatin A Hydrobromide |
|
298197-04-3 |
详细
|
| CPI-637 |
|
1884712-47-3 |
详细
|
| Acebilustat |
|
943764-99-6 |
详细
|
| UK-371804 |
|
256477-09-5 |
详细
|
| CNV 1014802 hydrochloride |
(2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 |
934240-31-0 |
详细
|
| Onatasertib(CC 223,ATG-008) |
|
1228013-30-6 |
详细
|
| EPZ015866,GSK3203591 |
|
1616391-87-7 |
详细
|
| BDA-366 |
|
1909226-00-1 |
详细
|
| Lys-SMCC-DM1 |
|
1281816-04-3 |
详细
|
|
5-氯-2,3-二氢苯并呋喃-3-胺 |
769-21-1 |
详细
|
| CP-609754 |
|
1190094-64-4 |
详细
|
| ABT-639 |
|
1235560-28-7 |
详细
|
| STK16-IN-1 |
|
1223001-53-3 |
详细
|
| PLX4032 (Vemurafenib) |
维罗非尼 |
918504-65-1 |
详细
|
| DM1-SMe |
N2'-去乙酰基-N2'-[3-(甲基二硫基)-1-氧代丙基]美登素 |
138148-68-2 |
详细
|
|
4-丙烯酰胺苯并-18-冠醚 |
68865-32-7 |
详细
|
| Compound A |
|
1665301-36-9 |
详细
|
| LACS-13909 |
|
2160546-07-4 |
详细
|
| Blu-263 |
|
|
详细
|
| Pexmetinib (ARRY-614) |
|
945614-12-0 |
详细
|
| PF-573228 |
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 |
869288-64-2 |
详细
|
| Vipadenant(BIIB-014) |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-胺 |
442908-10-3 |
详细
|
| GSK189254A |
|
720690-73-3 |
详细
|
| SHP099 |
|
1801747-42-1 |
详细
|
| 4-(Chloromethyl)-2,6-dimethylpyridine |
2,6-二甲基-4-氯甲基吡啶 |
120739-87-9 |
详细
|
| Lersivirine(UK 453061) |
3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈 |
473921-12-9 |
详细
|
| Voxtalisib (XL765, SAR245409) |
2-氨基-8-乙基-4-甲基-6-(1H-吡唑-3-基)吡啶并[2,3-d]嘧啶-7(8H)-酮 |
934493-76-2 |
详细
|
| PFI-3 |
|
1819363-80-8 |
详细
|
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
详细
|
| MK-4101 |
|
935273-79-3 |
详细
|
| CWHM-12 |
|
1564286-55-0 |
详细
|
| Defactinib hydrochloride |
地法替尼盐酸盐 |
1073160-26-5 |
详细
|
| Voxelotor(GBT440, GTx011) |
|
1446321-46-5 |
详细
|
| 5-chloro-2,3-dihydro-benzofuran-3-ol |
|
5590-44-3 |
详细
|
| BAY-876 |
|
1799753-84-6 |
详细
|
| AMG-3969 |
|
1361224-53-4 |
详细
|
| Amifloxacin |
氨氟沙星 |
86393-37-5 |
详细
|
| AC 55541 |
(E)-N-(2-(2-(1-(3-溴苯基)亚乙基)肼基)-2-氧代-1-(4-氧代-3,4-二氢邻苯二甲嗪-1-基)乙基)苯甲酰胺 |
916170-19-9 |
详细
|
| CB-103 |
6-[4-(叔丁基)苯氧基]吡啶-3-胺 |
218457-67-1 |
详细
|
| ON1231320 |
|
1312471-39-8 |
详细
|
| Lanraplenib (GS-9876) |
|
1800046-95-0 |
详细
|
| WAY-181187(SAX-187) |
|
554403-49-5 |
详细
|
| GNE-3511 |
|
1496581-76-0 |
详细
|
| J-14 |
|
1043854-13-2 |
详细
|
| Elacridar |
依克立达 |
143664-11-3 |
详细
|
| Dasotraline hydrochloride |
达索曲林盐酸盐 |
675126-08-6 |
详细
|
| CGP 60474 |
3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡啶-2-基)氨基)丙-1-醇 |
164658-13-3 |
详细
|
| Lasmiditan hydrochloride |
|
613677-28-4 |
详细
|
| (±)-BAY-1251152 |
|
1610358-53-6 |
详细
|
| GSK046 |
|
2474876-09-8 |
详细
|
| Elacridar hydrochloride |
依克立达盐酸盐 |
143851-98-3 |
详细
|
| PIK-90 |
|
677338-12-4 |
详细
|
| AM-2394 |
|
1442684-77-6 |
详细
|
| IDO-IN-7(Navoximod) |
IDO-IN-7抑制剂 |
1402837-78-8 |
详细
|
| NIK SMI1 |
|
1660114-31-7 |
详细
|
| DGY-06-116 |
|
|
详细
|
| JNJ-42165279 |
N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺 |
1346528-50-4 |
详细
|
| GSK-843 |
|
1601496-05-2 |
详细
|
| IM156 |
|
1422365-93-2 |
详细
|
| JNJ40411813 |
|
1127498-03-6 |
详细
|
| HG-10-102-01 |
|
1351758-81-0 |
详细
|
| MK-3903 |
|
1219737-12-8 |
详细
|
| JTE 013 |
|
383150-41-2 |
详细
|
| THZ2 |
|
1604810-84-5 |
详细
|
| CDKI-73 |
|
1421693-22-2 |
详细
|
| BVT948 |
|
39674-97-0 |
详细
|
| Verinurad |
|
1352792-74-5 |
详细
|
| Bictegravir |
比克替拉韦 |
1611493-60-7 |
详细
|
| TRC253 |
|
2110426-27-0 |
详细
|
| Lasmiditan |
2,4,6-三氟-N-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺 |
439239-90-4 |
详细
|
| FIT-039 |
|
1113044-49-7 |
详细
|
| GSK6853 |
|
1910124-24-1 |
详细
|
| faldaprevir |
|
801283-95-4 |
详细
|
| Opicapone |
|
923287-50-7 |
详细
|
| GDC0575 |
|
1196541-47-5 |
详细
|
| THZ531 |
|
1702809-17-3 |
详细
|
| EX229 |
|
1219739-36-2 |
详细
|
| GPR40 agonist 4 |
2-[[4-[(2'-氯[1,1'-联苯]-3-基)甲氧基]苯基]磺酰基]乙酸 |
2102196-57-4 |
详细
|
| MRT 68921 dihydrochloride |
|
2080306-21-2 |
详细
|
| Ceapin-A7 |
|
2323027-38-7 |
详细
|
| Letermovir |
乐特莫韦 |
917389-32-3 |
详细
|
| ML365 |
|
947914-18-3 |
详细
|
| TRULI |
|
1424635-83-5 |
详细
|